Company Overview and News
Billionaire activist investor Carl Icahn nominated a five-person slate of his employees and business associates to replace the SandRidge Energy Inc board of directors on Monday, escalating his fight for control of the U.S. shale oil producer.
SandRidge Energy Inc, which is in the middle of a proxy fight with top shareholder Carl Icahn, said on Monday it would evaluate buyout offers, including one from Icahn.
April 5 (Reuters) - U.S. oil and gas producer Bonanza Creek Energy Inc on Thursday named Eric Greager as its new chief executive officer effective April 11, replacing Seth Bullock, who served as interim CEO since June 2017.
Carl Icahn intends to nominate a full slate of candidates to the board of SandRidge Energy Inc., SD -0.74% saying that the current board’s overseeing a strategic review “is likely to be value destructive.”
HOUSTON (Reuters) - Activist investor Carl Icahn said on Wednesday he plans to nominate directors who would push for a sale of SandRidge Energy Inc and may make an offer himself for the embattled Oklahoma City oil and gas producer.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
The oil and gas explorer has seen its stock sink 37% since October 2016, despite a restructuring that wiped out $4 billion in debt. Activist investor Carl Icahn is threatening a proxy fight, and last week SandRidge rejected a merger that would have valued the once $11-billion company at just $589 million.
Even as stocks were suffering from trade-related tensions last week, one key sector was steadily notching up gains. While all other key sector SPDRs of the S&P 500 incurred losses over the last five trading days, the Energy Select Sector SPDR (XLE) gained 2.6% over the same period. Analysts feel that this long-neglected sector is poised for a rebound on the back of earnings growth and impressive valuations.
Chicago, IL – March 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Concho Resources Inc. (CXO - Free Report) , Continental Resources, Inc. (CLR - Free Report) , Northern Oil and Gas, Inc. (NOG - Free Report) , WildHorse Resource Development Corp.
Following the release of EIA crude inventory numbers, renewed geopolitical tensions in the Middle East and Fed announcement on interest rates, oil prices jumped above the psychologically important $65 per barrel level on Wednesday. West Texas Intermediate crude for May delivery gained $1.63, or 2.6%, to settle at $65.17 a barrel in electronic trading yesterday - the highest since early February.
(Reuters) - Oil and gas producer SandRidge Energy Inc (SD.N) said on Monday it rejected smaller rival Midstates Petroleum Co Inc’s (MPO.N) offer to buy the company in an all-stock deal.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET